Compression-Induced Phase Transitions of Bicalutamide

The formation of solid dispersions with the amorphous drug dispersed in the polymeric matrix improves the dissolution characteristics of poorly soluble drugs. Although they provide an improved absorption after oral administration, the recrystallization, which can occur upon absorption of moisture or during solidification and other formulation stages, serves as a major challenge. This work aims at understanding the amorphization-recrystallization changes of bicalutamide. Amorphous solid dispersions with poly(vinylpyrrolidone-co-vinyl acetate) (PVP/VA) were obtained by either ball milling or spray drying.

The applied processes led to drug amorphization as confirmed using X-ray diffraction and differential scanning calorimetry. Due to a high propensity towards mechanical activation, the changes of the crystal structure of physical blends of active pharmaceutical ingredient (API) and polymer upon pressure were also examined. The compression led to drug amorphization or transition from form I to form II polymorph, depending on the composition and applied force.

The formation of hydrogen bonds confirmed using infrared spectroscopy and high miscibility of drug and polymer determined using non-isothermal dielectric measurements contributed to the high stability of amorphous solid dispersions. They exhibited improved wettability and dissolution enhanced by 2.5- to 11-fold in comparison with the crystalline drug. The drug remained amorphous upon compression when the content of PVP/VA in solid dispersions exceeded 20% or 33%, in the case of spray-dried and milled systems, respectively. Download full publication here: Compression-Induced Phase Transitions of Bicalutamide

Szafraniec-Szczęsny, J.; Antosik-Rogóż, A.; Knapik-Kowalczuk, J.; Kurek, M.; Szefer, E.; Gawlak, K.; Chmiel, K.; Peralta, S.; Niwiński, K.; Pielichowski, K.; Paluch, M.; Jachowicz, R. Compression-Induced Phase Transitions of Bicalutamide. Pharmaceutics 2020, 12, 438.

Keywords: amorphous solid dispersions; physical stability; bicalutamide; Kollidon®VA64; dissolution; compression, Sodium lauryl sulfate,